Cite
MLA Citation
G Baldin et al.. “Efficacy and safety of switching to dolutegravir plus emtricitabine/tenofovir disoproxil fumarate (TDF) or elvitegravir/cobicistat/emtricitabine/TDF in virologically suppressed HIV‐infected patients in clinical practice: results from a multicentre, observational study.” HIV medicine, vol. 20, no. 2, 2019, pp. 164–168. http://access.bl.uk/ark:/81055/vdc_100076793220.0x000028